These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7500866)

  • 1. Mapping the biodistribution and catabolism of 5-fluorouracil in tumor-bearing rats by chemical-shift selective 19F MR imaging.
    Brix G; Bellemann ME; Haberkorn U; Gerlach L; Bachert P; Lorenz WJ
    Magn Reson Med; 1995 Sep; 34(3):302-7. PubMed ID: 7500866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective 19F MR imaging of 5-fluorouracil and alpha-fluoro-beta-alanine.
    Brix G; Bellemann ME; Zabel HJ; Bachert P; Lorenz WJ
    Magn Reson Imaging; 1993; 11(8):1193-201. PubMed ID: 8271906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct detection of intratumoral 5-fluorouracil trapping using metabolic 19F MR imaging.
    Brix G; Bellemann ME; Gerlach L; Haberkorn U
    Magn Reson Imaging; 1999 Jan; 17(1):151-5. PubMed ID: 9888408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: a comparative animal study.
    Brix G; Bellemann ME; Haberkorn U; Gerlach L; Lorenz WJ
    Nucl Med Biol; 1996 Oct; 23(7):897-906. PubMed ID: 8971857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical modulation of the catabolism and tissue uptake of the anticancer drug 5-fluorouracil by 5-bromovinyluracil: assessment with metabolic (19)F MR imaging.
    Brix G; Bellemann ME; Haberkorn U
    Magn Reson Med; 1999 Nov; 42(5):936-43. PubMed ID: 10542353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
    Harada M; Nishitani H; Shirahama T; Koga K; Miura I
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra- and extracellular fluorouracil uptake: assessment with contrast-enhanced metabolic F-19 MR imaging.
    Brix G; Bellemann ME; Gerlach L; Haberkorn U
    Radiology; 1998 Oct; 209(1):259-67. PubMed ID: 9769841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.
    Li CW; Negendank WG; Padavic-Shaller KA; O'Dwyer PJ; Murphy-Boesch J; Brown TR
    Clin Cancer Res; 1996 Feb; 2(2):339-45. PubMed ID: 9816177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver.
    Murphy-Boesch J; Li CW; He L; Padavic-Shaller KA; Negendank W; Brown TR
    Magn Reson Med; 1997 Mar; 37(3):321-6. PubMed ID: 9055218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma.
    Schlemmer HP; Bachert P; Semmler W; Hohenberger P; Schlag P; Lorenz WJ; van Kaick G
    Magn Reson Imaging; 1994; 12(3):497-511. PubMed ID: 8007780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 19F-[1H] nuclear Overhauser effect and proton decoupling of 5-fluorouracil and alpha-fluoro-beta-alanine.
    Krems B; Bachert P; Zabel HJ; Lorenz WJ
    J Magn Reson B; 1995 Aug; 108(2):155-64. PubMed ID: 7648013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.
    Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M
    Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 5-fluorouracil pharmacokinetics following intraperitoneal and intravenous administration using in vivo 19F magnetic resonance spectroscopy.
    Glaholm J; Leach MO; Collins D; al Jehazi B; Sharp JC; Smith TA; Adach J; Hind A; McCready VR; White H
    Br J Radiol; 1990 Jul; 63(751):547-53. PubMed ID: 2390689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of 5-fluorouracil anabolism by methotrexate and trimetrexate in two rat solid tumor models, Walker 256 carcinosarcoma and Novikoff hepatoma, as evaluated by 19F-magnetic resonance spectroscopy.
    Katzir I; Shani J; Wolf W; Chatterjee-Parti S; Berman E
    Cancer Invest; 2000; 18(1):20-7. PubMed ID: 10701363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
    Martino R; Malet-Martino MC; Vialaneix C; Lopez A; Bon M
    Drug Metab Dispos; 1987; 15(6):897-904. PubMed ID: 2893719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
    Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
    NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
    Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
    Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy.
    Adams ER; Leffert JJ; Craig DJ; Spector T; Pizzorno G
    Cancer Res; 1999 Jan; 59(1):122-7. PubMed ID: 9892196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo 19F NMR comparative study of 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and an FT-uracil coadministration system in mouse tumors.
    Kanazawa Y; Kurogi S; Shinohara S; Noda Y; Masuda K
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):774-8. PubMed ID: 8020119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hepatic impairment on the metabolism of fructose and 5-fluorouracil, as studied in fatty liver models using in vivo 31P-MRS and 19F-MRS.
    Otsuka H; Harada M; Koga K; Nishitani H
    Magn Reson Imaging; 1999 Feb; 17(2):283-90. PubMed ID: 10215484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.